SCHEMBL6958004

SCHEMBL6958004

NCCCC1CCCCN1c1ccncc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHKA P35790 1/20 0.40
MAPT P10636 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
HIF1A Q16665 1/20 0.36
TDP1 Q9NUW8 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
LMNA P02545 1/20 0.35
HRH1 P35367 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
POLB P06746 1/20 0.33
MAOA P21397 1/20 0.33
TERT O14746 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
ROCK2 O75116 1/20 0.32
ROCK1 Q13464 1/20 0.32
RAD52 P43351 1/20 0.32
FFAR1 O14842 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6963258 0.85 MEN1 (0.40) CHKAMAPTNPSR1ALDH1A1HPGD
SCHEMBL7364016 0.84 MEN1 (0.40) CHKAMAPTNPSR1ALDH1A1HPGD
SCHEMBL27504809 0.82 MEN1 (0.48) CHKAMAPTNPSR1ALDH1A1HPGD
SCHEMBL7497500 0.81 FFAR1 (0.40) L3MBTL1POLBFFAR1
SCHEMBL2872196 0.80 CHKA (0.41) CHKAMAPTNPSR1ALDH1A1HPGD
Bromide SCHEMBL8168549 0.79 CCNE1 (0.34) MAPTALDH1A1HPGDHIF1A
SCHEMBL17240312 0.75 ALDH1A1 (0.42) MAPTNPSR1ALDH1A1TDP1L3MBTL1
SCHEMBL7401883 0.73 FFAR1 (0.58) FFAR1
SCHEMBL6649685 0.73 CHKA (0.41) CHKAMAPTNPSR1TDP1L3MBTL1
SCHEMBL28140950 0.70 FFAR1 (0.44) POLBFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6620815-B1 Selective antagonists for human alpha 1A receptors; benign prostatic hyperplasia, impotency, cardiac arrhythmia treatment; anticholesterol agents; intraocular pressure reduction SYNAPTIC PHARMACEUTICAL CORPORATION 2003-09-16 US disclosed
EP-0988295-A4 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMA CORP (US) 2003-08-13 EP disclosed
US-6159990-A Oxazolidinones as α1A receptor antagonists SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-12-12 US disclosed
EP-0988295-A1 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-03-29 EP disclosed
WO-1998057940-A1 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 1998-12-23 WO disclosed